CD3e (#78588 T, Cell Signaling Technology), CD11c (#64804, Cell Signaling Technology), CD19 (#3574, Cell Signaling Technology), F4/80 (#30325, Cell Signaling Technology), CD163 (#ab316218, Abcam), iNos (#CL594-18985, Proteintech), Krt8 (#ab53280, Abcam), Sftpc (#ab90716, Abcam), Cdc42 (#10155-1-AP, Proteintech), Claudin 5 (#ab131259, Abcam), Calponin (#CL594-13938, Proteintech, Chicago, IL, USA) and PKC zeta (aPKC
They are the experiment
Every compound above is sold strictly for laboratory and research purposes not for human consumption
Athira went public in September 2020 on the strength of the mechanism, raising 204 million dollars
A prospective clinical study of CTS treated in age- and sex-matched people with and without diabetes with a 52-month follow-up, showing that people with CTS and diabetes benefit from surgery